WAVE Life Sciences Ltd.
WVE
$6.79
-$0.28-3.96%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 544.59M | 602.07M | 196.22M | 208.48M | 243.08M |
| Total Receivables | -- | 1.28M | 10.00M | 1.62M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.23M | 8.40M | 6.65M | 6.70M | 8.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.46M | 3.08M | 2.62M | 6.76M | 6.84M |
| Total Current Assets | 561.27M | 614.81M | 215.49M | 223.56M | 257.98M |
|
|
|||||
| Total Current Assets | 561.27M | 614.81M | 215.49M | 223.56M | 257.98M |
| Net Property, Plant & Equipment | 18.07M | 19.86M | 22.07M | 24.29M | 26.15M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.20M | 3.82M | 3.82M | 4.51M | 4.22M |
| Total Assets | 583.54M | 638.50M | 241.38M | 252.36M | 288.34M |
|
|
|||||
| Total Accounts Payable | 19.06M | 15.70M | 14.49M | 14.66M | 14.36M |
| Total Accrued Expenses | 13.04M | 26.56M | 16.49M | 13.03M | 7.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.33M | 8.36M | 8.39M | 8.14M | 7.88M |
| Total Finance Division Other Current Liabilities | 9.40M | 44.44M | 46.53M | 51.58M | 57.31M |
| Total Other Current Liabilities | 9.40M | 44.44M | 46.53M | 51.58M | 57.31M |
| Total Current Liabilities | 49.83M | 95.07M | 85.90M | 87.41M | 87.37M |
|
|
|||||
| Total Current Liabilities | 49.83M | 95.07M | 85.90M | 87.41M | 87.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.39M | 9.41M | 11.38M | 13.58M | 15.72M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.60M | 7.80M | 11.68M | 4.23M | 5.58M |
| Total Liabilities | 71.81M | 112.27M | 108.96M | 105.22M | 108.67M |
|
|
|||||
| Common Stock & APIC | 1.86B | 1.84B | 1.40B | 1.36B | 1.34B |
| Retained Earnings | -1.35B | -1.33B | -1.27B | -1.22B | -1.17B |
| Treasury Stock & Other | -254.00K | -250.00K | -190.00K | -161.00K | -204.00K |
| Total Common Equity | 511.73M | 518.36M | 124.55M | 139.27M | 171.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 7.87M | 7.87M | 7.87M | 7.87M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 7.87M | 7.87M | 7.87M | 7.87M |
|
|
|||||
| Total Common Equity | 511.73M | 518.36M | 124.55M | 139.27M | 171.80M |
| Total Preferred Equity | -- | 7.87M | 7.87M | 7.87M | 7.87M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 511.73M | 526.23M | 132.42M | 147.14M | 179.68M |
|
|
|||||